BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 37066050)

  • 1. Handling the different requirements for commercial and investigational MNC collections by apheresis.
    Bobr A; Roberts T; Koepsell S; Williams SM; Schwartz J
    Cytotherapy; 2024 Apr; ():. PubMed ID: 38703156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KyoTox-e score; prediction of post-CAR-T prolonged thrombocytopenia using peripheral blood data before apheresis.
    Jo T; Arai Y; Kitawaki T; Nakamura N; Nishikori M; Mizumoto C; Kanda J; Yamashita K; Nagao M; Takaori-Kondo A
    Bone Marrow Transplant; 2024 Mar; 59(3):419-421. PubMed ID: 38110621
    [No Abstract]   [Full Text] [Related]  

  • 3. New Trends in Hemapheresis.
    Worel N; Buser A; Körper S
    Transfus Med Hemother; 2023 Apr; 50(2):75. PubMed ID: 37066052
    [No Abstract]   [Full Text] [Related]  

  • 4. Get Off on the Right Foot: How to Plan an Efficient Leukocytapheresis to Collect T Cells for CAR T-Cell Manufacturing.
    Piñeyroa JA; Cid J; Lozano M
    Transfus Med Hemother; 2023 Apr; 50(2):98-104. PubMed ID: 37066050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of cell collection efficiency in non-mobilized adult donors for autologous chimeric antigen receptor T-cell manufacturing.
    Piñeyroa JA; Cid J; Vlagea A; Carbassé G; Henao P; Bailo N; Ortiz-Maldonado V; Martínez-Cibrian N; Español M; Delgado J; Urbano-Ispizua Á; Lozano M
    Vox Sang; 2023 Mar; 118(3):217-222. PubMed ID: 36516201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of defined apheresis collection criteria in publicly available CAR-T cell clinical trial descriptions: Comprehensive review of over 600 studies.
    Thibodeaux SR; Aqui NA; Park YA; Schneiderman J; Su LL; Winters JL; Zubair AC; Schwartz J; Liu HD;
    J Clin Apher; 2022 Jun; 37(3):223-236. PubMed ID: 35085413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A guide to the collection of T-cells by apheresis for ATMP manufacturing-recommendations of the GoCART coalition apheresis working group.
    Worel N; Holbro A; Vrielink H; Ootjers C; Le Poole K; Beer-Wekking I; Rintala T; Lozano M; Bonig H
    Bone Marrow Transplant; 2023 Jul; 58(7):742-748. PubMed ID: 37024570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unstimulated apheresis for chimeric antigen receptor manufacturing in pediatric/adolescent acute lymphoblastic leukemia patients.
    Jarisch A; Rettinger E; Sörensen J; Klingebiel T; Schäfer R; Seifried E; Bader P; Bonig H
    J Clin Apher; 2020 Sep; 35(5):398-405. PubMed ID: 32750197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Depletion of high-content CD14
    Wang X; Borquez-Ojeda O; Stefanski J; Du F; Qu J; Chaudhari J; Thummar K; Zhu M; Shen LB; Hall M; Gautam P; Wang Y; Sénéchal B; Sikder D; Adusumilli PS; Brentjens RJ; Curran K; Geyer MB; Mailankhody S; O'Cearbhaill R; Park JH; Sauter C; Slovin S; Smith EL; Rivière I
    Mol Ther Methods Clin Dev; 2021 Sep; 22():377-387. PubMed ID: 34514029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apheresis for chimeric antigen receptor T-cell production in adult lymphoma patients.
    Harrer DC; Heidenreich M; Fante MA; Müller V; Haehnel V; Offner R; Burkhardt R; Herr W; Edinger M; Wolff D; Thomas S; Brosig A
    Transfusion; 2022 Aug; 62(8):1602-1611. PubMed ID: 35851959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Real-world characteristics of T-cell apheresis and clinical response to tisagenlecleucel in B-cell lymphoma.
    Cuffel A; Allain V; Faivre L; Di Blasi R; Morin F; Vercellino L; Chevalier MF; Desnoyer A; de Jorna R; Madelaine I; Parquet N; Brignier AC; Thieblemont C; Larghero J; Caillat-Zucman S; Mebarki M
    Blood Adv; 2022 Aug; 6(15):4657-4660. PubMed ID: 35728051
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.